# Microalgae as novel drug-delivery system for biomedical field

**Authors:** Yueyou Dai, Dandan Guo, Aifang Li, Wei Chen, Yi Yang, Shuxuan Li, Lianhe Yang, Shuying Feng

PMC · DOI: 10.1080/10717544.2026.2616930 · 2026-01-27

## TL;DR

Microalgae are being explored as a promising drug-delivery system due to their unique biological properties and potential for targeted treatment.

## Contribution

The paper provides a comprehensive overview of microalgae-based drug-delivery systems and strategies to enhance their efficiency and stability.

## Key findings

- Microalgae can efficiently carry drugs and achieve targeted release, avoiding toxicity and immunogenicity issues.
- Current research explores methods to improve the load capacity and stability of microalgae-based drug-delivery systems.
- Future advancements in cultivation and cost reduction may broaden clinical applications of microalgae drug-delivery systems.

## Abstract

Currently, increasing attention is being paid to the extraction and utilization of materials with special biological activities in nature or for medical applications. Owing to their unique biological characteristics and diverse application potential, microalgae are among the most promising materials in the field of biomedicine. Because of their diverse morphology and readily functionalizable surface, they can efficiently carry drugs and achieve targeted drug release. This can avoid major challenges of other methods related to toxicity, biocompatibility, and immunogenicity, which is important for the treatment of various diseases, particularly those related to hypoxia. Despite the distinct advantages of microalgae over other biomaterials, several challenges persist in their practical application. Herein, we comprehensively describe the current state of research on the microalgae drug-delivery system (MDDS). In particular, we explore various microalgae-based strategies and methods to improve the load capacity and stability of DDS, and to achieve target positioning and tracking. With further research on microalgae, their application prospects in DDSs will broaden. In the future, researchers will continue to explore the features and advantages of microalgae; develop more efficient, safe, and accurate DDSs; and provide more options for clinical treatments. Continued progress in microalgal cultivation technology and reduction in large-scale production costs will expand the clinical applications of MDDSs.

## Full-text entities

- **Diseases:** DDSs (MESH:D000014), B-lymphoma (MESH:D016393), phototoxicity (MESH:D017484), hypoxia (MESH:D000860), malaria (MESH:D008288), injuries (MESH:D014947), intestinal diseases (MESH:D007410), lung metastasis (MESH:D009362), type 1 diabetic (MESH:D003922), B-cell tumours (MESH:D015448), Gastrointestinal diseases (MESH:D005767), Diabetes (MESH:D003920), NR-deficient (MESH:C536415), inflammation (MESH:D007249), pneumonia (MESH:D011014), breast cancer (MESH:D001943), Pulmonary diseases (MESH:D008171), DDS (MESH:D030321), Gaucher's disease (MESH:D005776), allergic reactions (MESH:D004342), Skin diseases (MESH:D012871), colorectal cancer (MESH:D015179), bacterial infections (MESH:D001424), neuroblastoma (MESH:D009447), endotoxemia (MESH:D019446), microbial infections (MESH:D015163), cytotoxic (MESH:D064420), skin and soft-tissue infections (MESH:D018461), Tumour (MESH:D009369), hypoxic (MESH:D002534), melanoma (MESH:D008545), type 2 diabetic (MESH:D003924)
- **Chemicals:** CBZ (MESH:D002220), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), O2 (MESH:D010100), streptozotocin (MESH:D013311), ROS (MESH:D017382), starch (MESH:D013213), astaxanthin (MESH:C005948), ATP (MESH:D000255), B12 (MESH:C034730), phosphonic acids (MESH:D010757), indomethacin (MESH:D007213), Fe3O4 (MESH:C000499), propanediol (MESH:D011409), chloroquine phosphate (MESH:C023676), gentamicin (MESH:D005839), amine (MESH:D000588), DE (MESH:C033787), Carbon (MESH:D002244), Pd (MESH:D010165), silicon (MESH:D012825), ethanol (MESH:D000431), polystyrene (MESH:D011137), MOF (MESH:D000073396), beta-CD (MESH:C031215), polymer (MESH:D011108), ALG (MESH:D000464), silane (MESH:D012821), gallic acid (MESH:D005707), OTS (MESH:C061189), polysaccharides (MESH:D011134), water (MESH:D014867), hydroxyl (MESH:D017665), epoxy (MESH:D004853), EGCG (MESH:C045651), MTT (MESH:C070243), CO2 (MESH:D002245), SPR (MESH:C047668), phospholipid (MESH:D010743), isothiocyanate (MESH:C037152), prednisone (MESH:D011241), caprylic acid (MESH:C031492), chlorophyll (MESH:D002734), dextran (MESH:D003911), (3-aminopropyl)triethoxysilane (MESH:C477625), insulin (MESH:D007328), (3-glycidyloxypropyl)trimethoxysilane (MESH:C000616917), Chitosan (MESH:D048271), ruthenium (MESH:D012428), amifostine (MESH:D004999), Magnesium (MESH:D008274), Au (MESH:D006046), lipid (MESH:D008055), glutathione (MESH:D005978), vitamin B12 (MESH:D014805), ellagic acid (MESH:D004610), DOX (MESH:D004317), short-chain fatty acids (MESH:D005232), omega-3 fatty acids (MESH:D015525), carotenoids (MESH:D002338), SP (MESH:C000604007)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rhinomonas (genus) [taxon 46951], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], PX clade (clade) [taxon 569578], Lactiplantibacillus plantarum (species) [taxon 1590], Limnospira platensis (species) [taxon 118562], Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa (species) [taxon 287], Dunaliella salina (species) [taxon 3046], Bacillus subtilis (species) [taxon 1423], Haematococcus lacustris (species) [taxon 44745], Spirulina (suborder) [taxon 551299], Thalassiosira pseudonana (species) [taxon 35128], Human papillomavirus 16 (serotype) [taxon 333760], Phaeodactylum tricornutum (species) [taxon 2850], Chlamydomonas reinhardtii (species) [taxon 3055], Chlorella vulgaris (species) [taxon 3077]
- **Cell lines:** 769-P — Homo sapiens (Human), Renal cell carcinoma, Cancer cell line (CVCL_1050), SK-BR-3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), MDA-MB 231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), ChL-CHL — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0212), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12854229/full.md

---
Source: https://tomesphere.com/paper/PMC12854229